Jacobs Levy Equity Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-177,460
| Closed | -$15.1M | – | 1003 |
|
|
2023
Q2 | $15.1M | Sell |
177,460
-10,423
| -6% | -$887K | 0.09% | 232 |
|
|
2023
Q1 | $15.5M | Sell |
187,883
-55,240
| -23% | -$4.57M | 0.1% | 223 |
|
|
2022
Q4 | $19.1M | Sell |
243,123
-9,682
| -4% | -$761K | 0.13% | 198 |
|
|
2022
Q3 | $18.7M | Sell |
252,805
-20,477
| -7% | -$1.52M | 0.15% | 175 |
|
|
2022
Q2 | $17.8M | Buy |
273,282
+251,253
| +1,141% | +$16.4M | 0.14% | 184 |
|
|
2022
Q1 | $1.39M | Buy |
+22,029
| New | +$1.39M | 0.01% | 700 |
|
|
2020
Q1 | – | Sell |
-5,130
| Closed | -$589K | – | 1038 |
|
|
2019
Q4 | $589K | Sell |
5,130
-1,730
| -25% | -$199K | 0.01% | 765 |
|
|
2019
Q3 | $865K | Buy |
6,860
+2,200
| +47% | +$277K | 0.01% | 635 |
|
|
2019
Q2 | $561K | Buy |
4,660
+1,460
| +46% | +$176K | 0.01% | 724 |
|
|
2019
Q1 | $280K | Sell |
3,200
-4,081
| -56% | -$357K | ﹤0.01% | 847 |
|
|
2018
Q4 | $728K | Sell |
7,281
-920
| -11% | -$92K | 0.01% | 666 |
|
|
2018
Q3 | $940K | Sell |
8,201
-47,500
| -85% | -$5.44M | 0.01% | 658 |
|
|
2018
Q2 | $5M | Sell |
55,701
-3,170
| -5% | -$284K | 0.08% | 305 |
|
|
2018
Q1 | $4.31M | Buy |
58,871
+53,011
| +905% | +$3.88M | 0.07% | 310 |
|
|
2017
Q4 | $340K | Hold |
5,860
| – | – | 0.01% | 831 |
|
|
2017
Q3 | $263K | Buy |
+5,860
| New | +$263K | 0.01% | 813 |
|
|
2016
Q3 | – | Sell |
-16,550
| Closed | -$480K | – | 1059 |
|
|
2016
Q2 | $480K | Sell |
16,550
-2,662
| -14% | -$77.2K | 0.01% | 768 |
|
|
2016
Q1 | $672K | Sell |
19,212
-15,900
| -45% | -$556K | 0.01% | 659 |
|
|
2015
Q4 | $1.13M | Buy |
35,112
+880
| +3% | +$28.4K | 0.02% | 428 |
|
|
2015
Q3 | $1.11M | Buy |
+34,232
| New | +$1.11M | 0.02% | 467 |
|